Managing oncology clinical trials during COVID-19 pandemic

Managing oncology clinical trials during COVID-19 pandemic

São Paulo city is the epicenter of the Brazilian COVID-19 pandemic. The Instituto do Cancer do Estado de São Paulo is currently conducting 161 multinational sponsored trials plus 116 in house studies in the oncologic population. There are 242 currently active participants and 180 patients in follow-...

Full description

Bibliographic Details
Main Authors:	Roberto J. Arai, Camila M.V. Moniz, André T.C. Chen, Milena P. Mak, Roger Chammas, Paulo M. Hoff
Format:	Article
Language:	English
Published:	Elsevier 2020-09-01
Series:	Contemporary Clinical Trials Communications
Subjects:	Oncology clinical trials COVID-19
Online Access:	http://www.sciencedirect.com/science/article/pii/S2451865420301216

Similar Items

Prevalence of drug-drug interactions in oncology patients enrolled on National Clinical Trials Network oncology clinical trials
by: Lauren A. Marcath, et al.
Published: (2018-11-01)

Implementing oncology clinical trials in Nigeria: a model for capacity building
by: Atara Ntekim, et al.
Published: (2020-08-01)

Beyond Participation: Evaluating the Role of Patients in Designing Oncology Clinical Trials
by: Eliya Farah, et al.
Published: (2023-09-01)

Future vision for the quality assurance of oncology clinical trials
by: Thomas eFitzGerald, MD, et al.
Published: (2013-03-01)

The Impact of the COVID-19 Pandemic on Oncology Care and Clinical Trials
by: Jennyfa K. Ali, et al.
Published: (2021-11-01)

Diversity in Oncology Clinical Trials: Current Landscape for Industry-Sponsored Clinical Trials in Asia
by: Dany Habr, et al.
Published: (2023-12-01)

Spotlight on landmark oncology trials: the latest evidence and novel trial designs
by: Helena Earl, et al.
Published: (2017-06-01)

Birth and Maturation of Cardio-Oncology
by: Deepak L. Bhatt, MD, MPH
Published: (2019-09-01)

Trial-level factors affecting accrual and completion of oncology clinical trials: A systematic review
by: Cherie L. Hauck, et al.
Published: (2021-12-01)

Sponsorship of oncology clinical trials in the United States according to age of eligibility
by: Dylan V. Neel, et al.
Published: (2020-07-01)

A Database of Drug Repurposing Clinical Trials in Oncology
by: Pan Pantziarka, et al.
Published: (2021-11-01)

Impact of coronavirus disease 2019 pandemic on good clinical practice trials in oncology
by: Veronica Agostinelli, et al.
Published: (2023-10-01)

Pharmacogenomics Testing in Phase I Oncology Clinical Trials: Constructive Criticism Is Warranted
by: Tristan M. Sissung, et al.
Published: (2022-02-01)

Quality improvements in radiation oncology clinical trials
by: Koren Smith, et al.
Published: (2023-01-01)

Barriers and Facilitators to Conducting Oncology Clinical Trials in the UAE
by: Humaid O. Al-Shamsi
Published: (2022-11-01)

Theory and practice of clinical trials in oncology and hematology
by: N. V. Zhukov
Published: (2016-08-01)

Discontinuation and nonpublication of clinical trials in orthopaedic oncology
by: Gurbinder Singh, et al.
Published: (2024-02-01)

Bioinformatics for Precision Medicine in Oncology: principles and application to the SHIVA clinical trial
by: Nicolas eServant, et al.
Published: (2014-05-01)

Financial Conflicts of Interest Change After a High-Impact Clinical Trial Publication in Oncology
by: Craig L. Cambridge, et al.
Published: (2020-07-01)

Integrating Palliative Care for Patients on Clinical Trials: Opportunities for Oncology Nurses
by: Betty Ferrell, et al.
Published: (2020-01-01)

Clinical outcome assessment trends in clinical trials—Contrasting oncology and non‐oncology trials
by: Yeonju Kim, et al.
Published: (2023-08-01)

Looking ahead in early-phase trial design to improve the drug development process: examples in oncology
by: Alyssa M. Vanderbeek, et al.
Published: (2023-06-01)

Perspective: rethinking therapeutic strategies in oncology
by: Edward F. Patz, et al.
Published: (2024-01-01)

Phase 0 clinical trials in oncology new drug development
by: Umesh Chandra Gupta, et al.
Published: (2011-01-01)

Integration of healthy volunteers in early phase clinical trials with immuno-oncological compounds
by: Igor Radanovic, et al.
Published: (2022-08-01)

Precision Oncology: Evolving Clinical Trials across Tumor Types
by: I-Wen Song, et al.
Published: (2023-03-01)

Optimal predictive probability designs for randomized biomarker-guided oncology trials
by: Emily C. Zabor, et al.
Published: (2022-12-01)

Clinical significance in pediatric oncology randomized controlled treatment trials: a systematic review
by: A. Fuchsia Howard, et al.
Published: (2018-10-01)

Trends in Women’s Leadership of Oncology Clinical Trials
by: Ithai Waldhorn, et al.
Published: (2022-06-01)

Computational approaches for drug repurposing in oncology: untapped opportunity for high value innovation
by: Shraddha M. Dalwadi, et al.
Published: (2023-05-01)

Application of Real-World Data to External Control Groups in Oncology Clinical Trial Drug Development
by: Timothy A. Yap, et al.
Published: (2022-01-01)

Characteristics and research status among clinical trials in cardio‐oncology by bibliometric and visualized analysis
by: Liu Lini, et al.
Published: (2023-06-01)

Drug-drug interactions in subjects enrolled in SWOG trials of oral chemotherapy
by: Lauren A. Marcath, et al.
Published: (2021-03-01)

Neoadjuvant pazopanib and molecular analysis of tissue response in renal cell carcinoma
by: Christopher G. Wood, et al.
Published: (2020-11-01)

Clinical trials in oncology /
by: 214712 Green, Stephanie, et al.
Published: (2003)

Analyzing factors associated with clinical trial publication in radiation oncology
by: Newsha Nikzad, et al.
Published: (2022-10-01)

Partial tumor irradiation plus pembrolizumab in treating large advanced solid tumor metastases
by: Mark C. Korpics, et al.
Published: (2023-05-01)

Phase I study of adjuvant immunotherapy with autologous tumor-infiltrating lymphocytes in locally advanced cervical cancer
by: He Huang, et al.
Published: (2022-08-01)

Increasing patient participation in oncology clinical trials
by: Jie Chen, et al.
Published: (2023-02-01)

Precision Immuno-Oncology in NSCLC through Gender Equity Lenses
by: Jennifer Marks, et al.
Published: (2024-04-01)